Growth Metrics

Evaxion A (EVAX) Net Income towards Common Stockholders Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -10.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 34.98%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 34.98%
Dec 31, 2025 4.86%
Sep 30, 2025 40.24%
Jun 30, 2025 -0.44%
Mar 31, 2025 35.14%
Dec 31, 2024 14.09%
Sep 30, 2024 28.30%
Jun 30, 2024 3.13%
Mar 31, 2024 31.84%
Dec 31, 2023 5.00%
Sep 30, 2023 -12.29%
Jun 30, 2023 -16.01%
Mar 31, 2023 -62.12%